AstraZeneca breast cancer treatment gets FDA priority review
AstraZeneca breast cancer treatment gets FDA priority review
Reuters: Health
AstraZeneca Plc said on Thursday that the U.S. drug regulator will give a speedy review to its experimental breast cancer treatment, which could put the British drugmaker in direct competition with bigger rival Roche Holding AG.
No comments:
Post a Comment